title: [Preliminary study of the association of tuberculosis and pregnancy: about 9 cases].
abstract: From June 1668 to June 2002, we have studied at the Pneumology Clinic of Fann Hospital, pulmonary tuberculosis among 9 pregnant women. The average age was 26 years old and the consultation's delay was 5 months. All our patients had a productive cough and an evening fever coupled with a thoracic pain and a deterioration of the general condition in 7 patients (77.7%). The dyspnea and the heamoptisis were a consultation motive for 44.4% and 33.3% of the patients. The evolution of pregnancies was 29 weeks. They had all benefited from the intradermal reaction with tuberculin (IDRT) with an average diameter of 11.7 mm; it was negative in one patient. The bacilloscopy systematically done was negative in 2 patients. At the front thoracic radiography, we have found basal lesions unilateral in more than half of the cases and excavated in 44.4% of cases. They benefited from an antitubercular treatment (Rifampicine (R) + Isoniazide (H) + Pyrazinamide (Z) with a good clinical, biological, bacteriological and radiological progression. From the obstetrical point of view, there was an abortion after 5 months, 2 premature deliveries between the 7th and the 8th month and 6 normal deliveries at 9 months. Babies born from bacillary mothers systematically received an antitubercular treatment with breast feeding. In conclusion, pregnant women with pulmonary tuberculosis essentially pose a therapeutic problem, requiring a good collaboration between the lung specialist, the gyneco-obstetrician and the pediatrician. It could be more hazardous not to act early in treating a pregnant women with pulmonary tuberculosis.
authors.affiliation: Clinique de Pneumologie du CHU de Fann, Dakar.
authors.forename: N O
authors.initials: NO
authors.lastname: Toure
authors.forename: Y
authors.initials: Y
authors.lastname: Dia
authors.forename: A
authors.initials: A
authors.lastname: Diatta
authors.forename: C M B
authors.initials: CM
authors.lastname: Ndiaye
authors.forename: Belinga A
authors.initials: BA
authors.lastname: Sah
authors.forename: A
authors.initials: A
authors.lastname: Niang
authors.forename: N
authors.initials: N
authors.lastname: Fall
authors.forename: M
authors.initials: M
authors.lastname: Kane
authors.forename: F
authors.initials: F
authors.lastname: Mbaye
authors.forename: A
authors.initials: A
authors.lastname: Cisse
authors.forename: A A
authors.initials: AA
authors.lastname: Hane
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D006469:Hemoptysis / Q000209:etiology; D006801:Humans; D007400:Interprofessional Relations; D010347:Patient Care Planning; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*
chemical_list: D000995:Antitubercular Agents